May 19, 2026 OT VIII Bob Duggan, the majority stockholder of his company Summit Therapeutics Inc. (SMMT) has watched roughly $7.6 billion of his personal paper wealth evaporate. When added to the […]
May 19, 2026 Even as Scientologist OT VIII Bob Duggan watched his company’s stock drop again under $16.00, a federal court development from May 11 was working its way through the institutional […]
Scientology billionaire Bob Duggan and his pharmaceutical company Summit Therapeutics are now facing a tsunami of legal threats due to allegations of serious misconduct. When fourteen plaintiffs’ firms across thirty-nine months independently […]
May 1, 2026 — 8:30 AM Los Angeles News Desk Update. Summit Therapeutics filed its Q1 2026 Form 10-Q with the SEC at 5:00 PM Eastern on April 30, 2026 — one […]
Chart: May 1, 2026 – Market Chameleon. Summit Therapeutics after-hours volume spikes to 34.3x as algorithmic material event detection defeats sophisticated disclosure engineering. May 1, 2026 – 1:00 AM Los Angeles News […]
Bob Duggan’s Summit Therapeutics goes off the cliff at end of the trading day on April 30, 2026 Bob Duggan, the reclusive Scientology OT8 and controlling shareholder of Summit Therapeutics, absorbed roughly […]
On Tuesday, April 21, 2026, the London Gazette published a First Gazette Notice initiating the strike-off of Summit (Oxford) Limited, United Kingdom company number 04636431. The notice states that unless cause is […]
MarketScreener Chart: The financial chart is devastating. We think Bob Duggan is not running a pharmaceutical company. Rather, the publicly available information indicates that that he is managing a controlled demolition while extracting […]
At age 80, Scientologist billionaire Bob Duggan still surfs. However, these days he and his 1960’s-era longboard are surrounded by sharks. Bob Duggan and his Summit Therapeutics (NASDAQ: SMMT) are simultaneously facing […]
Scientology billionaire Bob Duggan and his wife and co-CEO Maky Zanganeh of Summit Therapeutics (SMMT) have been targeted for a possible class action lawsuit by the powerhouse securities law firm Pomerantz LLP. […]